Intellectual Property Protection and Enforcement Manual - Ipr-policy.eu
Intellectual Property Protection and Enforcement Manual - Ipr-policy.eu
Intellectual Property Protection and Enforcement Manual - Ipr-policy.eu
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Br<strong>and</strong> <strong>Protection</strong> <strong>Manual</strong><br />
Johnson & Johnson & Co., Inc.<br />
Johnson & Johnson (J&J) is the world’s most comprehensive <strong>and</strong> broad-based manufacturer<br />
of health care products <strong>and</strong> related services for the consumer, pharmac<strong>eu</strong>tical, <strong>and</strong> medical<br />
devices <strong>and</strong> diagnostics markets. More than 250 Johnson & Johnson operating companies<br />
employ approximately 121,000 people in 57 countries <strong>and</strong> sell products throughout the world.<br />
The fundamental objective of Johnson & Johnson is to provide scientifically sound, highquality<br />
products <strong>and</strong> services.<br />
For Johnson & Johnson, protecting its products from counterfeiting is a top priority—but not<br />
its first. As David Howard, director, Product <strong>Protection</strong>, Global Br<strong>and</strong> Integrity says, “We have<br />
a single focus; it’s called our company credo. It maintains that our first priority is the men <strong>and</strong><br />
women, the patients, <strong>and</strong> the doctors. The entire br<strong>and</strong> integrity effort is built around reassuring<br />
<strong>and</strong> protecting the source of supply of goods to users <strong>and</strong> consumers.” So J&J’s focus<br />
becomes how it can accomplish this goal through product development, packaging, sourcing,<br />
<strong>and</strong> distribution networks.<br />
The Johnson & Johnson Team<br />
J&J has three market segments: consumer, medical device <strong>and</strong> diagnostics, <strong>and</strong> medicines <strong>and</strong><br />
nutritionals. Within these market segments are team members <strong>and</strong> organizations dedicated to<br />
br<strong>and</strong> integrity activities. For example, the medical device <strong>and</strong> diagnostics team, led by a vice<br />
president of br<strong>and</strong> integrity, includes dedicated individuals focusing on product <strong>and</strong> packaging<br />
protection technologies; a person who h<strong>and</strong>les supply chain integrity <strong>and</strong> channel management;<br />
<strong>and</strong> an employee dedicated to market monitoring <strong>and</strong> enforcement. The Johnson & Johnson<br />
team also has representatives from each of the corporate entities—legal, regulatory affairs,<br />
communications, corporate security, <strong>and</strong> trademarks. The diversity of talent <strong>and</strong> background<br />
leverages each team’s ability to develop a successful br<strong>and</strong> integrity operation, including anticounterfeiting<br />
strategies.<br />
Risk Liability<br />
Authentication <strong>and</strong> tracking technology for J&J are a means to an end. They are part of a comprehensive<br />
effort to protect its customers from dangerous <strong>and</strong> defective counterfeit products. To<br />
effectively decide how to best protect a product, J&J developed an assessment tool that asks 35<br />
questions specific to that product, focusing on the potential risk of counterfeiting. Based on the<br />
assessment, the product is then processed through a scoring system that awards points for the<br />
number of covert protection features. “The goal is to develop overt <strong>and</strong> covert features that best<br />
meet the needs of the individual product at risk,” says Howard. “The scoring of authentication<br />
features considers form factor of the item being protected as well as product <strong>and</strong> packaging<br />
dynamics. The closer you can get product protection features to the product, the easier it is to<br />
authenticate.” This system is available to all J&J’s operating companies to analyze risk potential<br />
Page 31